Skip to main content
Pay Bill Portals

Detecting molecular residual disease with Signatera

Published Date

Design and analytical validation of SignateraTM, the first ctDNA assay custom-built for detecting MRD and assessing treatment response.

Download PDF

Design and analytical validation of Signatera™, the first ctDNA assay custom-built for detecting MRD and assessing treatment response.